Urticaria, the second most common drug eruption after exanthematous drug eruptions, 1 is characterized by episodic short-lived swellings of the skin, oropharnyx, or genitalia. Transient leakage of ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

BOSTON -- Treatment with an investigational anti-KIT monoclonal antibody induced clinically meaningful responses in the two most common forms of chronic inducible urticaria, a dose-ranging phase II ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Barzolvolimab is an anti-KIT monoclonal antibody. 75% of ...